Evrofarma SA (EVROF) - Total Liabilities
Based on the latest financial reports, Evrofarma SA (EVROF) has total liabilities worth €34.79 Million EUR (≈ $40.67 Million USD) as of December 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Evrofarma SA - Total Liabilities Trend (2014–2022)
This chart illustrates how Evrofarma SA's total liabilities have evolved over time, based on quarterly financial data. See Evrofarma SA current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Evrofarma SA Competitors by Total Liabilities
The table below lists competitors of Evrofarma SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Genesem Inc
KQ:217190
|
Korea | ₩35.31 Billion |
|
Gujarat Apollo Industries Limited
NSE:GUJAPOLLO
|
India | Rs574.57 Million |
|
Y/KNOT S.A.
AT:YKNOT
|
Greece | €29.83 Million |
|
Solytech Enterprise Corp
TW:1471
|
Taiwan | NT$127.48 Million |
|
Daekyo
KO:019680
|
Korea | ₩297.83 Billion |
|
Maxiparts Ltd
AU:MXI
|
Australia | AU$97.45 Million |
|
DarioHealth Corp
NASDAQ:DRIO
|
USA | $40.90 Million |
|
Cassiar Gold Corp
V:GLDC
|
Canada | CA$4.99 Million |
Liability Composition Analysis (2014–2022)
This chart breaks down Evrofarma SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EVROF company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.11 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Evrofarma SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Evrofarma SA (2014–2022)
The table below shows the annual total liabilities of Evrofarma SA from 2014 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | €34.79 Million ≈ $40.67 Million |
+2.57% |
| 2021-12-31 | €33.91 Million ≈ $39.65 Million |
+1.47% |
| 2020-12-31 | €33.42 Million ≈ $39.08 Million |
+13.96% |
| 2019-12-31 | €29.33 Million ≈ $34.29 Million |
-9.97% |
| 2018-12-31 | €32.58 Million ≈ $38.08 Million |
-5.21% |
| 2017-12-31 | €34.37 Million ≈ $40.18 Million |
+2.43% |
| 2016-12-31 | €33.55 Million ≈ $39.23 Million |
-2.90% |
| 2015-12-31 | €34.55 Million ≈ $40.40 Million |
-9.08% |
| 2014-12-31 | €38.00 Million ≈ $44.43 Million |
-- |
About Evrofarma SA
Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.